Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

2017; Elsevier BV; Volume: 1; Issue: 21 Linguagem: Inglês

10.1182/bloodadvances.2017005926

ISSN

2473-9537

Autores

Antonio R. Lucena‐Araujo, Diego A. Pereira‐Martins, Luisa C A Koury, Pedro L. França-Neto, Juan Luiz Coelho‐Silva, Virgínia Mara de Deus Wagatsuma, Raul Antônio Morais Melo, Rosane Bittencourt, Kátia Bórgia Barbosa Pagnano, Ricardo Pasqüini, Carlos Chiattone, Evandro M. Fagundes, Maria de Lourdes Chauffaille, Stanley L. Schrier, Martin S. Tallman, Raul C. Ribeiro, David Grimwade, Arnold Ganser, Bob Löwenberg, Francesco Lo‐Coco, Miguel Á. Sanz, Nancy Berliner, Eduardo Magalhães Rego,

Tópico(s)

Glioma Diagnosis and Treatment

Resumo

Key Points BAALC expression is significantly lower in APL compared with other subsets of AML and healthy volunteers. BAALC overexpression can independently predict shorter DFS in patients with high-risk disease.

Referência(s)